MII (maladie de Crohn/colite)

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Estomac / intestins » MII (maladie de Crohn/colite)

04. Juin 2020

Dépistage / diagnostic

Recherche de documentation spécialisée

MII (maladie de Crohn/colite)

Troubles fonctionnels

Écriture:

Page 1 de 1873


	Articles 1 - 20 / 37451

	Effect of ulcerative colitis duration on the usefulness of immunochemical fecal occult blood test result as a disease activity biomarker. Int J Colorectal Dis Ishida N, Miyazu T, Matsuura T, Takano R, Tamura S, Kagami T, Tani S, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Furuta T, Sugimoto K. PMID: 32472230 [PubMed - as supplied by publisher]
	Identification and diagnosis of Crohn disease and ulcerative colitis in children. J Paediatr Child Health Day AS, Lemberg DA. PMID: 32468706 [PubMed - as supplied by publisher]
	Alpha-Linolenic Acid Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Inflammation Kim J, Ahn M, Choi Y, Kang T, Kim J, Lee NH, Kim GO, Shin T. PMID: 32468499 [PubMed - as supplied by publisher]
	A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease. Bone Marrow Transplant Burt RK, Craig R, Yun L, Halverson A, Quigley K, Arnautovic I, Han X. PMID: 32467584 [PubMed - as supplied by publisher]
	TRPV Subfamily (TRPV2, TRPV3, TRPV4, TRPV5, and TRPV6) Gene and Protein Expression in Patients with Ulcerative Colitis. J Immunol Res Toledo Mauriño JJ, Fonseca-Camarillo G, Furuzawa-Carballeda J, Barreto-Zuñiga R, Martínez Benítez B, Granados J, Yamamoto-Furusho JK. PMID: 32455137 [PubMed - in process]
	REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY. Dig Dis Barberio B, Zingone F, Frazzoni L, D''Incà R, Maccarone MC, Ghisa M, Massimi D, Lorenzon G, Savarino E. PMID: 32450562 [PubMed - as supplied by publisher]
	Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the PhaseÂ 3 Clinical Program. Adv Ther Sandborn WJ, Vermeire S, Tyrrell H, Hassanali A, Lacey S, Tole S, Tatro AR, Etrolizumab Global Steering Committee.. PMID: 32445184 [PubMed - as supplied by publisher]
	Upregulation of Fecal Epithelial Heparanase mRNA Is Associated with Increased Ulcerative Colitis Activity and Cancerization Risk. Dig Dis Sci Cui Y, Zhang J, Chen Y, Chen LG. PMID: 32445051 [PubMed - as supplied by publisher]
	Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK)Â Inhibitors. Clin Exp Gastroenterol Troncone E, Marafini I, Del Vecchio Blanco G, Di Grazia A, Monteleone G. PMID: 32440190 [PubMed]
	Interleukin-1Î² as a Predictor of Glucocorticoid Response in Ulcerative Colitis. Digestion Okuno H, Ogino H, Ihara E, Nishioka K, Iboshi Y, Chinen T, Ochiai T, Akiho H, Nakamura K, Gotoda T, Ogawa Y. PMID: 32434191 [PubMed - as supplied by publisher]
	Effects of sDR5-Fc fusion protein on infant mice with ulcerative colitis via the TRAIL-DR5 pathway. J Biol Regul Homeost Agents Cai LJ, Wang MF, Wang XL, Zhu HF, Chen XZ. PMID: 32425017 [PubMed - in process]
	Meta-Analysis of Expression Profiling Data Indicates Need for Combinatorial Biomarkers in Pediatric Ulcerative Colitis. J Immunol Res Li X, Lee EJ, Gawel DR, Lilja S, Schäfer S, Zhang H, Benson M. PMID: 32411805 [PubMed - in process]
	Gene Expression Profiling of Mediators Associated with the Inflammatory Pathways in the Intestinal Tissue from Patients with Ulcerative Colitis. Mediators Inflamm Camarillo GF, Goyon EI, Zuñiga RB, Salas LAS, Escárcega AEP, Yamamoto-Furusho JK. PMID: 32410873 [PubMed - in process]
	Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary - a population-based study. PLoS One Kunovszki P, Milassin Á, Gimesi-Országh J, Takács P, Szántó K, Bálint A, Farkas K, Borsi A, Lakatos PL, Szamosi T, Molnár T. PMID: 32407408 [PubMed - in process]
	Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000Res Porter RJ, Kalla R, Ho GT. PMID: 32399194 [PubMed - in process]
	Slit2/Robo1 Mitigates DSS-induced Ulcerative Colitis by Activating Autophagy in Intestinal Stem Cell. Int J Biol Sci Xie J, Li L, Deng S, Chen J, Gu Q, Su H, Wen L, Wang S, Lin C, Qi C, Zhang Q, Li J, He X, Li W, Wang L, Zheng L. PMID: 32398956 [PubMed - in process]
	Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials. Trials Chen YM, Deng JM, Wen Y, Chen B, Hou JT, Peng B, Zhang SJ, Mi H, Jiang QL, Wu XL, Liu FB, Chen XL. PMID: 32398112 [PubMed - in process]
	Similar Clinical Outcomes of Early and Late Anti-TNF Initiation for Ulcerative Colitis: A Nationwide Population-Based Study. Yonsei Med J Han M, Jung YS, Cheon JH, Park S. PMID: 32390361 [PubMed - in process]
	Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis. Int J Colorectal Dis Tang LL, Feng WZ, Cheng JJ, Gong YN. PMID: 32388604 [PubMed - in process]
	Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life. Medicine (Baltimore) Ozer M, Bengi G, Colak R, Cengiz O, Akpinar H. PMID: 32384473 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 37451

Page 1 de 1873



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité